Basic Alesse Information

• INN (International Nonproprietary Name): Levonorgestrel and Ethinyl Estradiol
• Brand Names Available In United Kingdom: not specified
• ATC Code: G03AA07
• Forms & Dosages: Oral tablet; common presentation Alesse 21 (21 active tablets) and Alesse 28 (21 active + 7 placebo); typical strength 0.1 mg levonorgestrel + 0.02 mg ethinyl estradiol per active tablet
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription Only (Rx) in all jurisdictions

Important Instructions & UK Warnings

Always get Alesse (levonorgestrel and ethinyl estradiol) on prescription via your GP, sexual health clinic or a registered online pharmacy.

Alesse is Prescription Only (Rx) across jurisdictions.

Bring a current medicines list to any appointment and check MHRA guidance with the clinician or pharmacist.

If you have any absolute contraindication do not use Alesse and discuss alternatives immediately.

Absolute contraindications include a history of deep vein thrombosis or pulmonary embolism, stroke, current breast cancer, severe liver disease, migraine with aura and uncontrolled hypertension.

Store blister packs in the original packaging at 15–30°C and protect from moisture and heat when travelling.

Keep tablets out of reach of children and do not freeze.

Pick a consistent day and time to take the pill and use phone reminders or pill apps to help adherence.

Pharmacists at Boots, LloydsPharmacy and Superdrug can provide private counselling and quick checks for interactions and suitability.

If you are under 25 and sexually active, consider combined services at sexual health clinics for contraception review.

In Scotland, Wales and Northern Ireland prescriptions are free; in England standard NHS prescription charges apply.

Supply Checklist For Pharmacy:

• Confirm prescription and identity.
• Check blood pressure, BMI and smoking status.
• Review current medicines and herbal remedies.
• Record counselling session including start date, pill time and missed‑pill advice.

Morning Vs Evening Dosing

Choose a time you can stick to for daily dosing to reduce breakthrough bleeding and maintain contraceptive reliability.

Alesse is one active tablet daily in 21 or 28 tablet packs with a fixed schedule.

Morning dosing works well for many people who prefer a routine around breakfast.

Evening dosing suits shift workers or those who prefer a nightly medication check.

If you miss a pill by a few hours, take it when you remember.

If the gap is more than 24 hours follow the missed‑dose rules in section 9.

Use phone alarms, pill apps or the blister’s day labels to help adherence.

Adherence Tips:

• Set a daily alarm on your phone or smartwatch.
• Keep the blister on the bedside or breakfast table as a visual cue.
• Use a pill app that logs doses and gives reminders.
• Ask a pharmacy to provide a written quick‑start card and follow‑up date.

Taking With Or Without Meals

Food does not meaningfully affect absorption for combined pills like Alesse.

Take Alesse with or without food according to personal comfort and routine.

If you feel nauseous try taking the tablet with a small breakfast such as toast and tea.

Avoid heavy binge drinking around dosing time because vomiting within two hours can reduce absorption.

If vomiting happens within two hours treat it as a missed dose and follow the missed‑pill protocol.

For those with morning sickness consider switching to an evening dose so the pill is taken after an evening snack.

Timing Comparison:

• Morning: Good for consistent daytime routines and quick‑start when starting on day 1 of period.
• Evening: Better for people with irregular work hours or morning nausea.

Everyday Use & Best Practices

Daily Routine And Adherence

Small practical changes make daily contraceptive pills much easier to manage.

Pair the pill with an existing habit such as brushing teeth or breakfast for better adherence.

Carry a spare blister in your bag when travelling in case of delays or emergencies.

If you change routine often, discuss blister‑style options with your pharmacist to maintain coverage.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Certain conditions make Alesse unsuitable and are labelled absolute contraindications.

Absolute contraindications include active thromboembolism, history of stroke or coronary disease, current breast cancer, severe liver disease, migraine with aura and uncontrolled hypertension.

Relative cautions include obesity (BMI over 30), smoking more than 15 cigarettes a day especially over age 35, well‑controlled hypertension or diabetes, family history of clotting disorders and gallbladder disease.

Before prescribing, NHS clinicians and pharmacists will review blood pressure, BMI, smoking and medical history.

MHRA alerts and Yellow Card reports are used to refine local risk management when new signals appear.

Screening Checklist:

• Current or past blood clots — DVT or PE.
• Cardiovascular history — stroke or coronary artery disease.
• Breast cancer or hormone‑sensitive tumours.
• Liver disease or severe hepatic impairment.
• Migraine with aura or uncontrolled hypertension.

Activities To Limit (Driving, Work Safety)

Alesse typically does not impair driving or routine work duties.

If you experience severe dizziness, fainting or sudden visual disturbance avoid driving or hazardous activities until symptoms settle.

People with jobs that need prolonged immobilisation, such as long flights or post‑operative recovery, should discuss thrombosis prevention with their prescriber.

Simple Safety Steps:

• Avoid heavy alcohol on days you start a new pill due to increased nausea risk.
• Report any unusual leg pain or breathlessness immediately.
• Plan for temporary thrombosis prophylaxis if advised prior to major surgery or prolonged travel.

Dosage & Adjustments

General Regimen (NHS Guidance)

The standard regimen is one active tablet daily for 21 days followed by seven days of either placebo tablets (28‑day pack) or no tablets (21‑day pack), then repeat.

Typical tablet strengths commonly supplied are 0.1 mg levonorgestrel with 0.02 mg ethinyl estradiol per active tablet.

Starting on day 1 of a period gives immediate contraceptive protection.

Quick‑start is possible at other times but requires seven days’ backup contraception.

Missed‑pill Protocol Summary:

• If one active tablet is missed, take it as soon as remembered, even if this means two in one day.
• If two or more active tablets are missed, take the most recent missed tablet as soon as possible, discard other missed tablets and use backup contraception for seven days.
• If placebo tablets are missed, discard and continue as normal.

Special Cases (Elderly, Comorbidities)

Alesse is not indicated post‑menopause or in women over 50.

It is contraindicated in severe hepatic impairment due to risk of accumulation and adverse effects.

Not recommended in renal failure and caution is advised for mild to moderate hepatic or renal impairment.

Adolescents who have reached menarche may use standard adult dosing when clinically appropriate.

Patients with controlled chronic conditions such as hypertension or diabetes without vascular complications may be prescribed Alesse with regular monitoring.

Monitoring Checklist:

• Regular blood pressure checks.
• Periodic lipid profile and glucose monitoring if clinically indicated.
• Reassessment of VTE risk factors at routine reviews.

User Testimonials

Positive Reports From UK Patients

Many patients find low‑dose levonorgestrel and ethinyl estradiol tablets well tolerated for cycle control.

Users often report less breast tenderness and nausea with lower oestrogen formulations compared with higher‑dose combined pills.

Clear blister packs help with adherence and make daily dosing straightforward.

Pharmacist counselling at Boots and community sexual health clinics is frequently praised for making switches between brands easier.

Short Anonymised Quotes:

• "Cycle regularity improved after a couple of months and the blister pack is easy to follow."
• "My pharmacist explained the missed‑pill rules clearly and checked my other medicines."
• "Lower oestrogen made morning sickness manageable and breast tenderness reduced."

Common Challenges (Patient.info, NHS Forums)

Initial spotting, mood changes, nausea and headaches are commonly reported and often settle within two to three months.

Forums commonly raise questions on switching from one combined pill to another and on missing doses.

Accessing a specific brand name can cause anxiety because Alesse is frequently sold under generics or other brand names such as Aviane or Altavera in some markets.

When To Seek A Review:

• Persistent irregular bleeding beyond three months.
• Ongoing mood changes affecting daily life.
• Questions about brand equivalence or supply continuity.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Alesse formulations are prescription only, and should be obtained via a GP, sexual health clinic or registered online pharmacy.

High‑street chains including Boots, LloydsPharmacy and Superdrug will dispense equivalent products under prescription and offer private consultations.

Generic equivalents commonly available internationally include Aviane and Altavera which contain the same active ingredients.

When collecting the medicine, always confirm the generic or brand name and the tablet strength with the pharmacist.

A quick Pharmacy Query Checklist:

• Confirm prescription validity and product name.
• Ask for private counselling on missed doses and side effects.
• Check for interactions with current medicines and herbal remedies.

Price Comparison (NHS Prescription Charge Vs Private)

Prescription policy varies across the UK and affects cost to the patient.

Prescriptions are free in Scotland, Wales and Northern Ireland; in England a standard NHS prescription charge applies per item.

Private prescriptions and consultations carry variable fees with online clinics and private providers.

Community pharmacy repeat dispensing can sometimes reduce out‑of‑pocket costs for regular users.

Look For Reliable Online Providers:

• Check GPhC registration for the online pharmacy.
• Confirm the prescriber is a UK‑based clinician for NHS prescription rules to apply.

In our online pharmacy, Alesse is available with discreet delivery to United Kingdom in 5–14 days.

What’s Inside & How It Works

Ingredients Overview

Alesse contains levonorgestrel (a progestogen) and ethinyl estradiol (an oestrogen).

Common tablet strength for many packs is 0.1 mg levonorgestrel plus 0.02 mg ethinyl estradiol per active tablet.

Available pack types include 21‑tablet blisters and 28‑tablet blisters with seven placebo tablets.

There are no non‑oral forms of this fixed combination described in the product information.

Mechanism Basics Explained Simply

The combined pill prevents pregnancy by suppressing ovulation.

It thickens cervical mucus to reduce sperm penetration and thins the uterine lining to lower implantation likelihood.

Levonorgestrel provides the progestogenic effect while ethinyl estradiol helps to stabilise the menstrual cycle.

The fixed combination is classified under ATC code G03AA07 and offers reliable systemic contraception when taken correctly.

Main Indications

Approved Uses (MHRA Listing)

Alesse is indicated solely for contraception and is a systemic hormonal contraceptive (ATC G03AA07).

It is a prescription‑only medicine and is not licensed as emergency contraception or for hormonal disorders beyond contraception.

Approved Indication Checklist:

• Primary indication: oral contraception.
• Not indicated for emergency contraception.
• Prescribing should follow MHRA and local NHS guidance.

Off‑Label Uses In UK Clinics

Clinicians sometimes use combined pills off‑label for cycle control or acne management after discussing risks and benefits with patients.

Such uses should be clearly recorded and alternatives considered where licensed options exist for heavy menstrual bleeding or acne.

Discussion Checklist For Off‑Label Use:

• Explain potential benefits and risks including VTE risk.
• Agree monitoring intervals and follow‑up plans.
• Document informed consent in the clinical record.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

There are no clinically significant food interactions for Alesse with typical UK foods and drinks such as tea and coffee.

Alcohol may worsen side effects such as nausea and dizziness and heavy drinking with subsequent vomiting may reduce absorption of the tablet.

If vomiting occurs within two hours of taking a tablet treat it as a missed dose and follow the missed‑pill guidance.

Drug Conflicts (MHRA Yellow Card Reports)

Certain medicines reduce effectiveness by enzyme induction, including some anticonvulsants, rifampicin and some HIV medicines.

St John’s wort is an herbal product that can reduce contraceptive effectiveness and should be disclosed to the prescriber or pharmacist.

Most antibiotics do not reduce effectiveness, with the notable exception of rifampicin and rifabutin.

Always tell the pharmacist about all medicines, over‑the‑counter products and herbal remedies.

Common Interaction Checklist:

• Enzyme inducers: some antiepileptics and rifampicin/rifabutin — may need alternative contraception.
• Herbal remedies: St John’s wort — avoid concomitant use unless advised by clinician.
• Report suspected adverse reactions to MHRA Yellow Card via your clinician or pharmacist.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent analyses in the UK and EU continue to support the contraceptive efficacy of low‑dose levonorgestrel and ethinyl estradiol combinations.

Post‑market surveillance through MHRA Yellow Card reporting remains important for refining VTE risk stratification.

Cohort studies between 2022 and 2025 show comparable tolerability to other low‑dose combined pills and a trend to fewer oestrogen‑related adverse events versus higher‑oestrogen formulations.

Key Findings Snapshot:

• Low‑dose combined pills maintain reliable contraceptive protection when taken correctly.
• Surveillance has focused on VTE risk stratification and patient selection.
• Comparative tolerability is favourable for lower oestrogen doses in terms of breast tenderness and nausea.

What This Means For Patients

For most healthy non‑smokers without contraindications, Alesse‑type pills remain a suitable first‑line combined oral contraceptive option.

Choice should be individualised considering BMI, smoking status, migraine history and family VTE risk.

Patients should report new worrying symptoms such as leg pain, sudden breathlessness or severe new headaches with aura without delay.

When To Contact A Clinician Or Emergency Services:

• New, severe leg pain or swelling.
• Sudden unexplained breathlessness or chest pain.
• Severe persistent headache with visual disturbance.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

The NHS offers several contraceptive options including other low‑dose combined pills such as Microgynon and Marvelon.

Progestogen‑only pills, implants and intrauterine devices are widely available and may suit people with oestrogen contraindications.

Non‑hormonal options such as the copper coil are available for those who prefer no hormonal exposure.

Pros/Cons Snapshot:

• Combined pills: good cycle control but carry a VTE risk.
• Progestogen‑only pill: suitable for breastfeeding women and those with oestrogen contraindications.
• IUD/Implant: long‑acting, low maintenance and highly effective without daily adherence.

When To Consider Switching

Switch if you develop new contraindications such as significant smoking, new migraine with aura or major cardiovascular risk factors.

Consider a switch if side effects are persistent or unacceptable, for example ongoing mood disturbance or bleeding problems.

Switching Between Similar Generics:

• Switching between levonorgestrel/ethinyl estradiol generics is usually straightforward under pharmacist supervision.
• Pharmacists can advise on brand equivalence and continuity of supply.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Products containing levonorgestrel and ethinyl estradiol are prescription only and subject to national approvals.

In the UK the MHRA oversees safety monitoring and licensing updates while NHS prescribing follows clinical criteria and local formularies.

Steps To Verify Product Authenticity:

• Check batch number and expiry date on the blister pack.
• Confirm the patient information leaflet is present and legible.
• Ask the pharmacist to confirm the product licence if unsure.

Reporting & Post‑Market Surveillance

Report suspected side effects via the MHRA Yellow Card scheme; pharmacists and clinicians often assist with submissions.

Manufacturers and generic suppliers such as Apotex, Teva and Sandoz are responsible for supply chain quality.

Reporting Checklist:

• Include product name, batch number and reaction details.
• Note date of onset and any concurrent medicines.
• Submit via MHRA Yellow Card online or through a healthcare professional.

FAQ Section

Common UK Patient Questions

Q: Can I get Alesse free?

A: Prescriptions are free in Scotland, Wales and Northern Ireland; in England standard NHS prescription charges apply.

Q: Is Alesse the same as Aviane?

A: They may contain the same INN—levonorgestrel and ethinyl estradiol—but always check dosage and pack type.

Q: What if I vomit after taking the pill?

A: Vomiting within two hours should be treated as a missed dose; follow the missed‑pill guidance in section 9.

Quick Answers & When To See A GP

If you have symptoms suggesting a VTE such as leg swelling or sudden breathlessness seek urgent medical attention.

Book a GP or sexual health clinic review for persistent bleeding, mood changes or concerns about contraceptive failure.

Keep a checklist of emergency contacts including your GP, local sexual health clinic and NHS 111.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Pharmacists should confirm relevant medical history including smoking, migraine and previous thrombotic events.

They should review current medicines, explain the 21/28 regimen and clearly outline missed‑pill rules and common side effects.

Storage advice should include keeping the blister at 15–30°C and protecting it from moisture and heat.

Provide a written quick‑start card and offer follow‑up contact details for clinic or GP support.

NHS Patient Support Advice

Patients should be advised about local NHS services for contraception review and how to change brands safely.

Use reminder tools and report adverse events via the MHRA Yellow Card scheme if needed.

Printable Checklist For Patients:

• Start date and chosen pill time.
• Backup contraception instructions for missed pills.
• Emergency contact points: GP, sexual health clinic, 111.

Delivery Across United Kingdom

City	Region	Delivery Time
London	England	5–7 days
Birmingham	West Midlands	5–7 days
Manchester	Greater Manchester	5–7 days
Glasgow	Scotland	5–7 days
Leeds	West Yorkshire	5–7 days
Liverpool	Merseyside	5–9 days
Bristol	South West England	5–7 days
Edinburgh	Scotland	5–7 days
Newcastle Upon Tyne	North East England	5–9 days
Sheffield	South Yorkshire	5–9 days
Cardiff	Wales	5–9 days
Belfast	Northern Ireland	5–9 days
Nottingham	Nottinghamshire	5–9 days